Tackling premenstrual syndrome

MeReC Bulletin

Volumn 13, Issue 3, 2003, Pages 1-12

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPRAZOLAM; AMMONIUM CHLORIDE; ANXIOLYTIC AGENT; BROMOCRIPTINE; BUSERELIN; CAFFEINE; DANAZOL; DIURETIC AGENT; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTROGEN; FLUOXETINE; GESTAGEN; GONADORELIN DERIVATIVE; GOSERELIN; IBUPROFEN; LEUPRORELIN; MEFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PLACEBO; PROGESTERONE; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SPIRONOLACTONE; UNINDEXED DRUG;

ACNE; ADULT; ANAMNESIS; BEHAVIOR; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DIET THERAPY; DISEASE RESISTANCE; DISEASE SEVERITY; DRUG COST; DRUG DEPENDENCE; DRUG INDICATION; DYSLIPIDEMIA; EMOTION; EXERCISE; FEMALE; FLUID RETENTION; HEADACHE; HEALTH CARE COST; HIRSUTISM; HOT FLUSH; HUMAN; LARYNX DISORDER; LIFESTYLE; LUTEAL PHASE; MEDICAL SPECIALIST; MENOPAUSE; MENSTRUAL CYCLE; NAUSEA; OSTEOPOROSIS; PERIPHERAL NEUROPATHY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; REVIEW; SIDE EFFECT; SYMPTOM; VERTIGO; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

EID: 0037222113     PISSN: 14655659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Stolberg M. The monthly malady: a history of premenstrual suffering. Med Hist 2000;44:301-22.
2. Greene R, Dalton K. The premenstrual syndrome. BMJ 1953;i:1007-14.
3. Wyatt K. Premenstrual syndrome. In: Barton S, editor. Clinical Evidence, Issue 8. London: BMJ Publishing Group; 2002. p.1972-91.
4. Managing the premenstrual syndrome. Drug Ther Bull 1992;30:69-72.
5. Ling FW. Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices. J Clin Psychiatry 2000;61(suppl 12):9-16.
6. Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behaviour: Experience from the United States, United Kingdom, and France. J Women's Health Gend Based Med 1999;8:1043-52.
7. Royal College of Obstetricians and Gynaecologists. Disorders of the menstrual cycle: Study group recommendations; 2000. Available from: URL: http://www.rcog.org.uk/ mainpages.asp?PageID=442
8. The American College of Obstetrics and Gynecology (ACOG) Committee on Practice Bulletins. Clinical management guidelines for obstetrician-gynecologists: Premenstrual syndrome. ACOG Pract Bull 2000;(15):1-8.
9. Wyatt K, Dimmock P, Jones P, et al. Efficacy of progesterone and progestogens in the management of premenstrual syndrome: systematic review. BMJ 2001;323:776-83.
10. Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management. J Psychiatry Neurosci 2000;25:459-68.
11. Johnson SR. Premenstrual syndrome therapy. Clin Obstet Gynecol 1998;41:405-21.
12. Stevenson C, Ernst E. Complementary/ alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol 2001;185:227-35.
13. Thys-Jacobs S, Starkey P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998;179:444-52.
14. Schellenberg R for the study group. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 2001;322:134-7.
15. National Association for Premenstrual Syndrome. Premenstrual syndrome - a clinical review, 1999 (Available from NAPS tel: 01732 760011).
16. Wyatt KM, Dimmock PW, Jones PW, et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 1999;318:1375-81.
17. London RS, Sundaram GS, Murphy L, et al. The effect of α-tocopherol on premenstrual symptomatology: a double-blind study. J Am Coll Nutr 1983;2:1115-22.
18. Budeiri D, Li Wan Po A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 1996;17:60-8.
19. Medicines Control Agency. What's new: Epogam and Efamast (gamolenic acid) - withdrawal of marketing authorisations, October 2002. Available from: URL: http://www.mca.gov.uk
20. British National Formulary. No. 44. London: British Medical Association/Royal Pharmaceutical Society of Great Britain; 2002.
21. Dimmock PW, Wyatt KM, Jones PW, et al. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;358:1131-6.
22. Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 1995;332:1529-34.
23. SSRIs for premenstrual dysphoric disorder. Drug Ther Bull 2002;40:70-1.
24. Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992;36:257-66.
25. Freeman EW, Kroll R, Rapkin A, et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med 2001;10:561-9.
26. Andersch B. Bromocriptine and premenstrual symptoms: a survey of double blind trials. Obstet Gynecol Surv 1983;38:643-6.
27. O'Brien PM, Abukhalil IEH. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase only danazol. Am J Obstet Gynecol 1999;180:18-23.